Clinical Trials on Neoplasms in Switzerland

Total 2022 results

Kantonsspital Aarau
University Hospital, Zürich; Center for Proton Therapy, Paul Scherrer Institute...

Unknown

Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma (HYPROSAR)

Soft Tissue Sarcoma

Switzerland
University of Zurich
Swiss Federal Institute of Technology

Completed

Breath Analysis in Healthy Controls

Healthy Subjects | Mass Spectrometry | Exhaled Breath

Switzerland
Amsterdam University Medical Centers (UMC), Location...
Mauna Kea Technologies

Recruiting

Confocal Laser Endomicroscopy VERification (CLEVER)

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Lung Neoplasm Malignant | Neoplasm of Lung

United States, Austria, Greece, Netherlands, Czechia, Italy, Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

CD34+ Selected ASCT for Aggressive Lymphomas (SAAL)

Malignant Non-Hodgkin Lymphomas

Switzerland
University Hospital Inselspital, Berne

Completed

Pedometer Activity Monitoring After ASCT (PAMAL)

Lymphoma | Myeloma | Autologous Stem Cell Transplantation | High-dose Chemotherapy

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

Lymphoma, B Cell

Switzerland
Kantonsspital Graubuenden

Unknown

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific

Switzerland
University of Zurich

Completed

OVEMP in Myasthenia

Myasthenia Gravis, Ocular

Switzerland
University Hospital, Basel, Switzerland

Completed

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Lymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neuroblastoma | Rhabdomyosarcoma

Switzerland, Germany
Sanofi

Completed

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Pancreatic Cancer

Switzerland
University Hospital, Basel, Switzerland

Completed

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Multiple Myeloma

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Lymphoma, B Cell

Switzerland
Life Molecular Imaging SA

Completed

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Diagnostic Imaging

Netherlands, Switzerland
University Hospital, Basel, Switzerland
St. Clara Research Ltd.

Terminated

Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.

Metastatic Pancreatic Cancer

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Lymphoma, Mucosa-Associated Lymphoid Tissue

Switzerland
University of Basel
University Hospital Inselspital, Berne; Foundation Cancer Research Switzerland

Unknown

A New Patient Reported Outcome Instrument to Assess Symptom Experience in Women With Vulvar Neoplasms (WOMAN-PRO) (WOMAN-PRO)

Women With Vulvar Intraephitelial Neoplasia or Vulvar Cancer

Switzerland, Germany
Klinik Valens

Active, not recruiting

High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study

Rehabilitation | Oncology | Post-Operative Condition | Deconditioning After Acute Hospital

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Terminated

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

Lymphoma, Mucosa-Associated Lymphoid Tissue

Switzerland
Centre Hospitalier Universitaire Vaudois

Terminated

Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

Carcinoma of Anal Canal

Switzerland
Cantonal Hospital of St. Gallen
Celgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...

Completed

Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma (BRd)

Multiple Myeloma

Switzerland
Nicole Lindenblatt
University Hospital, Zürich; Swiss Federal Institute of Technology; Zurich University... and other collaborators

Completed

Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function

Lymphedema | Secondary Lymphedema

Switzerland
University of Zurich
Swiss National Science Foundation

Completed

Breath Analysis in Chronic Obstructive Lung Disease (COPD)

COPD

Switzerland
UMC Utrecht

Completed

Phase I Platinum Based Chemotherapy Plus Indomethacin (PIFA)

Colorectal Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms

Netherlands, Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma

Splenic Marginal Zone Lymphoma

Switzerland
University Hospital Inselspital, Berne
Cantonal Hospital of St. Gallen; St. Claraspital AG; Cantonal Hospital of Zug

Terminated

Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer (IRE Qol)

Pancreatic Cancer

Switzerland
University of Zurich

Terminated

PET/MRI Perfusion and CT Perfusion in Solid Tumors (Perfusion)

CT Perfusion and MRI Perfusion in Solid Tumors

Switzerland
University Hospital Inselspital, Berne

Completed

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study (LIMIT)

Merkel Cell Carcinoma | Malignant Melanoma

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Lavage With Super-Oxidized Solution for Secondary Peritonitis (SOSPeritonitis)

Peritonitis

Switzerland
NovoCure Ltd.

Completed

NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NSCLC | Non-small Cell Lung Cancer

Switzerland
Christian Schwegler

Recruiting

Quality of Life Improvement During Chemotherapy (QoLMa)

Chemotherapy Effect | Breast Cancer Female

Switzerland
Southern Europe New Drug Organization
Novartis

Unknown

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Southern Europe New Drug Organization
Celgene Corporation

Unknown

Lenalidomide and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland, Italy
Southern Europe New Drug Organization
Novartis; Schering-Plough

Unknown

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Italy, Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC

Metastatic Castration-resistant Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer

Gastric Cancer

Switzerland, Italy
Sanofi

Completed

GILT Docetaxel - Non-Small Cell Lung Cancer

Lung Neoplasms

Spain, Germany, Switzerland
Plastic Surgery Group AG by Prof. Jian Farhadi

Completed

Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction

Breast Cancer

Switzerland
Terumo Europe N.V.
Federation Francophone de Cancerologie Digestive; Fundacion Clinic per a la...

Completed

LifePearl-Doxo Pharmacokinetic (PK) Study

HCC | Hepatocellular Carcinoma

Switzerland, Spain, Greece
Dominik Abt

Recruiting

Prostatic Artery Embolization in Advanced Prostate Cancer

Prostate Cancer | Bladder Outlet Obstruction

Switzerland
Günther Hofbauer

Terminated

Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses (IMOT001)

Actinic Keratosis

Switzerland
Kai-Uwe Schmitt, PhD, MEng, ICID

Recruiting

Digital Lifestyle Intervention for Lung Cancer Survivors After Inpatient Rehabilitation (QUALUCA)

Non-Small Cell Lung Cancer (NSCLC)

Switzerland
University Hospital, Basel, Switzerland
Schulzahnklinik Basel; Volkszahnklinik Basel

Completed

Salivary Cytokines as Biomarker for Oral Health (Cytosal)

Neoplasms

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Swiss Secondary Prevention and Rehabilitation Registry (SwissPR)

Cardiovascular Diseases (CVD)

Switzerland
Dario Valcarenghi

Completed

Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy

Post-surgery Radiotherapy

Switzerland
University Hospital, Basel, Switzerland

Completed

Smoking Cessation in Alcoholics

Smoking Cessation | Alcohol Consumption

Switzerland
University of Bern

Completed

Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis (Urticacomp)

Radiation Dermatitis

Switzerland
University Hospital, Basel, Switzerland

Completed

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Taste Disorder, Secondary, Sweet

Switzerland
University of Zurich

Completed

Determination of Blood Tumor Cells

Leukemia, Lymphocytic, Chronic, B-Cell | Abnormalities Cell Epithelial

Switzerland
Hoffmann-La Roche
Sanofi-Synthélabo (Schweiz) AG

Completed

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
Hoffmann-La Roche
Sanofi

Completed

An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

Colorectal Cancer

Switzerland

Clinical Trials on Neoplasms in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations